MSD has fleshed out its cardiovascular disease pipeline by licensing an oral Lp(a) inhibitor from China's Jiangsu Hengrui Pharma for $200 million upfront. The deal gives MSD exclusive rights to the ...

Kelun-Biotech has become the second drugmaker to bring a TROP2-directed antibody-drug conjugate to regulatory approval, getting a green light in China for sacituzumab tirumotecan (sac-TMT). The ...

Software can be expensive, but free programs have been a mainstay of the desktop experience for decades, and today's offerings are more powerful than ever. To keep things free, software developers ...

About Jochu Technology Co. Ltd. Jochu Technology Co., Ltd. engages in the manufacturing, processing, and trading of optoelectronic components, molds, and precision instruments. Its products include ...